Pembrolizumab in Patients With Metastatic Breast Cancer With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Alva, Ajjai S, Mangat, Pam K, Garrett-Mayer, Elizabeth, Halabi, Susan, Hansra, Damien, Calfa, Carmen J, Khalil, Maged F, Ahn, Eugene R, Cannon, Timothy L, Crilley, Pamela, Fisher, Julie G, Haslem, Derrick S, Shrestha, Sagun, Antonelli, Kaitlyn R, Butler, Nicole L, Warren, Sasha L, Rygiel, Andrew L, Ranasinghe, Shamika, Bruinooge, Suanna S, Schilsky, Richard L
Published in Journal of clinical oncology (01.08.2021)
Published in Journal of clinical oncology (01.08.2021)
Get full text
Journal Article
Cetuximab in Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Ovarian Cancer Without KRAS, NRAS, or BRAF Mutations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Fisher, Julie G., Tait, David, Garrett-Mayer, Elizabeth, Halabi, Susan, Mangat, Pam K., Schink, Julian C., Alvarez, Ricardo H., Veljovich, Dan, Cannon, Timothy L., Crilley, Pamela A., Pollock, Theodore, Calfa, Carmen J., Al Baghdadi, Tareq, Thota, Ramya, Fleming, Nicole, Cotta, Jared A., Rygiel, Andrew L., Warren, Sasha L., Schilsky, Richard L.
Published in Targeted oncology (01.12.2020)
Published in Targeted oncology (01.12.2020)
Get full text
Journal Article
Pertuzumab plus trastuzumab (P+T) in patients (Pts) with colorectal cancer (CRC) with ERBB2 amplification or overexpression: Results from the TAPUR Study
Gupta, Ranju, Garrett-Mayer, Elizabeth, Halabi, Susan, Mangat, Pam K., D'Andre, Stacy D., Meiri, Eyal, Shrestha, Sagun, Warren, Sasha L., Ranasinghe, Shamika, Schilsky, Richard L.
Published in Journal of clinical oncology (01.02.2020)
Published in Journal of clinical oncology (01.02.2020)
Get full text
Journal Article
Olaparib (O) in patients (pts) with prostate cancer with BRCA1/2 inactivating mutations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study
Pisick, Evan P., Garrett-Mayer, Elizabeth, Halabi, Susan, Mangat, Pam K., Yang, Eddy Shih-Hsin, Dib, Elie G., Burgess, Earle Frederick, Zakem, Michael Howard, Rohatgi, Nitin, Bilen, Mehmet Asim, Warren, Sasha L., Anderson, Sarah T., Rygiel, Andrew Lawrence, Schilsky, Richard L.
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Pembrolizumab (P) in patients (pts) with metastatic breast cancer (MBC) with high tumor mutational burden (HTMB): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Alva, Ajjai Shivaram, Mangat, Pam K., Garrett-Mayer, Elizabeth, Halabi, Susan, Alvarez, Ricardo H., Calfa, Carmen Julia, Khalil, Maged F., Ahn, Eugene R, Cannon, Timothy Lewis, Crilley, Pamela A., Fisher, Julie Gottlieb, Haslem, Derrick S., Shrestha, Sagun, Antonelli, Kaitlyn R., Butler, Nicole L., Warren, Sasha L., Rygiel, Andrew Lawrence, Ranasinghe, Shamika, Bruinooge, Suanna S., Schilsky, Richard L.
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article